These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1911883)

  • 1. Transformation and amplification of the K-fgf proto-oncogene in NIH-3T3 cells, and induction of metastatic potential.
    Damen JE; Greenberg AH; Wright JA
    Biochim Biophys Acta; 1991 Sep; 1097(2):103-10. PubMed ID: 1911883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor mediated alterations in drug resistance, and evidence of gene amplification.
    Huang A; Wright JA
    Oncogene; 1994 Feb; 9(2):491-9. PubMed ID: 7904743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The K-fgf/hst oncogene induces transformation through an autocrine mechanism that requires extracellular stimulation of the mitogenic pathway.
    Talarico D; Basilico C
    Mol Cell Biol; 1991 Feb; 11(2):1138-45. PubMed ID: 1990270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell motility, invasion, and malignancy induced by overexpression of K-FGF or bFGF.
    Taylor WR; Greenberg AH; Turley EA; Wright JA
    Exp Cell Res; 1993 Feb; 204(2):295-301. PubMed ID: 8440326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
    Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
    Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the K-fgf proto-oncogene is controlled by 3' regulatory elements which are specific for embryonal carcinoma cells.
    Curatola AM; Basilico C
    Mol Cell Biol; 1990 Jun; 10(6):2475-84. PubMed ID: 2188089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.
    Muschel RJ; Williams JE; Lowy DR; Liotta LA
    Am J Pathol; 1985 Oct; 121(1):1-8. PubMed ID: 3901774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF-8 isoforms differ in NIH3T3 cell transforming potential.
    MacArthur CA; Lawshé A; Shankar DB; Heikinheimo M; Shackleford GM
    Cell Growth Differ; 1995 Jul; 6(7):817-25. PubMed ID: 7547503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of mice against tumor growth by immunization with an oncogene-encoded growth factor.
    Talarico D; Ittmann M; Balsari A; Delli-Bovi P; Basch RS; Basilico C
    Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4222-5. PubMed ID: 2190216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of K-FGF or bFGF results in altered expression of matrix metalloproteinases: correlations with malignant progression and cellular invasion.
    Lo J; Hurta RA
    Cell Biol Int; 2002; 26(4):319-25. PubMed ID: 11991661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine growth stimulation by secreted Kaposi fibroblast growth factor but not by endogenous basic fibroblast growth factor.
    Wellstein A; Lupu R; Zugmaier G; Flamm SL; Cheville AL; Delli Bovi P; Basilico C; Lippman ME; Kern FG
    Cell Growth Differ; 1990 Feb; 1(2):63-71. PubMed ID: 1964794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased methotrexate resistance and dhfr gene amplification as a consequence of induced Ha-ras expression in NIH 3T3 cells.
    Wani MA; Xu X; Stambrook PJ
    Cancer Res; 1994 May; 54(9):2504-8. PubMed ID: 8162600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permissivity for methotrexate-induced DHFR gene amplification correlates with the metastatic potential of rat adenocarcinoma cells.
    Lücke-Huhle C
    Carcinogenesis; 1994 Apr; 15(4):695-700. PubMed ID: 8149482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells.
    McLeskey SW; Zhang L; Trock BJ; Kharbanda S; Liu Y; Gottardis MM; Lippman ME; Kern FG
    Br J Cancer; 1996 May; 73(9):1053-62. PubMed ID: 8624263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 3 is tumorigenic for mouse mammary cells orthotopically implanted in nude mice.
    Hajitou A; Calberg-Bacq CM
    Int J Cancer; 1995 Nov; 63(5):702-9. PubMed ID: 7591288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of methotrexate on transfected DNA stability in mammalian cells.
    Pallavicini MG; DeTeresa PS; Rosette C; Gray JW; Wurm FM
    Mol Cell Biol; 1990 Jan; 10(1):401-4. PubMed ID: 2403643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis.
    McLeskey SW; Zhang L; Kharbanda S; Kurebayashi J; Lippman ME; Dickson RB; Kern FG
    Breast Cancer Res Treat; 1996; 39(1):103-17. PubMed ID: 8738610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIH3T3 transfectant containing human K-ras oncogene shows enhanced metastatic activity after in vivo tumor growth or co-culture with fibroblasts.
    Takiguchi Y; Takahashi Y; Kuriyama T; Miyamoto T
    Clin Exp Metastasis; 1992 Sep; 10(5):351-60. PubMed ID: 1505125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic activity of the K-fgf/hst oncogene in neural transplants.
    Brüstle O; Aguzzi A; Talarico D; Basilico C; Kleihues P; Wiestler OD
    Oncogene; 1992 Jun; 7(6):1177-83. PubMed ID: 1375717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfection of cells with basic fibroblast growth factor and Kaposi fibroblast growth factor genes induce resistance to and receptor modulation of tumor necrosis factor.
    Aggarwal BB; Pocsik E; Totpal K
    FEBS Lett; 1995 Sep; 372(1):44-8. PubMed ID: 7556640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.